Thursday, February 2, 2017
AstraZeneca Net Profit Boosted by Licensing Deals
😊 43.5 😐 38.5 😵 17.9 AstraZeneca said net profit increased in the fourth quarter as a rise in proceeds from licensing deals offset sharply lower sales of the companys top-selling cholesterol pill, after several cheap generic versions launched earlier this year.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment